tradingkey.logo

Avantor Inc

AVTR
11.260USD
+0.465+4.31%
Close 02/06, 16:00ETQuotes delayed by 15 min
7.68BMarket Cap
LossP/E TTM

Avantor Inc

11.260
+0.465+4.31%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Avantor Inc

Currency: USD Updated: 2026-02-06

Key Insights

Avantor Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 83 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 12.66.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Avantor Inc's Score

Industry at a Glance

Industry Ranking
83 / 205
Overall Ranking
222 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Avantor Inc Highlights

StrengthsRisks
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Undervalued
The company’s latest PE is -94.77, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 697.26M shares, increasing 0.01% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 128.04K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.92.

Analyst Rating

Based on 20 analysts
Hold
Current Rating
12.662
Target Price
+17.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Avantor Inc is 6.97, ranking 115 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 1.62B, representing a year-over-year decrease of 5.28%, while its net profit experienced a year-over-year decrease of 1331.49%.

Score

Industry at a Glance

Previous score
6.97
Change
0

Financials

5.92

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.24

Operational Efficiency

8.69

Growth Potential

6.86

Shareholder Returns

7.15

Avantor Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Avantor Inc is 5.67, ranking 181 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -94.77, which is -171.04% below the recent high of 67.32 and -11.90% above the recent low of -106.04.

Score

Industry at a Glance

Previous score
5.67
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 83/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Avantor Inc is 6.10, ranking 171 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 13.00, with a high of 19.00 and a low of 12.00.

Score

Industry at a Glance

Previous score
6.10
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 20 analysts
Hold
Current Rating
12.662
Target Price
+17.35%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

63
Total
4
Median
6
Average
Company name
Ratings
Analysts
Avantor Inc
AVTR
20
Apple Inc
AAPL
48
Ge Vernova Inc
GEV
37
Tapestry Inc
TPR
23
FMC Corp
FMC
21
Verisk Analytics Inc
VRSK
19
1
2
3
...
13

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Avantor Inc is 6.73, ranking 97 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 12.55 and the support level at 10.32, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.36
Change
0.37

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.171
Sell
RSI(14)
46.619
Neutral
STOCH(KDJ)(9,3,3)
32.016
Buy
ATR(14)
0.416
Low Volatility
CCI(14)
-37.593
Neutral
Williams %R
67.935
Sell
TRIX(12,20)
-0.270
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
11.022
Buy
MA10
11.133
Buy
MA20
11.664
Sell
MA50
11.521
Sell
MA100
12.159
Sell
MA200
12.620
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Avantor Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 116.93%, representing a quarter-over-quarter decrease of 2.14%. The largest institutional shareholder is Van Duyn Dodge & E. Morris Cox, holding a total of 117.75M shares, representing 17.27% of shares outstanding, with 17.37% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
117.75M
+0.27%
The Vanguard Group, Inc.
Star Investors
65.80M
+1.98%
BlackRock Institutional Trust Company, N.A.
53.79M
-3.60%
Barrow Hanley Global Investors
Star Investors
34.55M
+10.76%
T. Rowe Price Investment Management, Inc.
32.93M
-41.72%
Greenhaven Associates, Inc.
20.50M
+11.95%
State Street Investment Management (US)
20.37M
-13.28%
Engine Capital Management, LP
19.72M
+258.27%
Clarkston Capital Partners, LLC
15.02M
+7.43%
New Mountain Capital, LLC
14.00M
--
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Avantor Inc is 5.39, ranking 82 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.94. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
5.39
Change
0
Beta vs S&P 500 index
0.94
VaR
+3.54%
240-Day Maximum Drawdown
+39.46%
240-Day Volatility
+53.59%

Return

Best Daily Return
60 days
+8.28%
120 days
+9.54%
5 years
+12.18%
Worst Daily Return
60 days
-5.15%
120 days
-23.21%
5 years
-23.21%
Sharpe Ratio
60 days
-0.36
120 days
-0.48
5 years
-0.41

Risk Assessment

Maximum Drawdown
240 days
+39.46%
3 years
+61.62%
5 years
+75.85%
Return-to-Drawdown Ratio
240 days
-0.90
3 years
-0.25
5 years
-0.17
Skewness
240 days
-1.64
3 years
-1.32
5 years
-1.03

Volatility

Realised Volatility
240 days
+53.59%
5 years
+40.06%
Standardised True Range
240 days
+4.89%
5 years
+6.64%
Downside Risk-Adjusted Return
120 days
-54.21%
240 days
-54.21%
Maximum Daily Upside Volatility
60 days
+26.93%
Maximum Daily Downside Volatility
60 days
+25.45%

Liquidity

Average Turnover Rate
60 days
+1.92%
120 days
+1.84%
5 years
--
Turnover Deviation
20 days
+92.48%
60 days
+60.32%
120 days
+53.54%

Peer Comparison

Healthcare Equipment & Supplies
Avantor Inc
Avantor Inc
AVTR
6.70 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI